Welcome to our dedicated page for Draganfly Common Shares news (Ticker: DPRO), a resource for investors and traders seeking the latest updates and insights on Draganfly Common Shares stock.
Draganfly Inc. (DPRO) is a global leader in the development and manufacturing of unmanned aerial vehicle (UAV) systems, software, and engineering services. Headquartered in Canada, the company has established a significant presence in the United States and internationally. Draganfly operates through three primary segments: Drones, Vital Intelligence, and Corporate.
The Drones segment is the cornerstone of Draganfly's operations, generating the majority of the company's revenue. This segment focuses on the production and sales of cutting-edge UAVs, catering to both hobbyists and industrial clients. Draganfly's drones are utilized in various applications, from recreational flying to critical missions involving emergency services, where they help make dangerous situations safer for personnel.
The Vital Intelligence segment leverages advanced technology to provide products that can measure vital signs from a distance, aiding in the early detection of symptoms among large groups. This innovative approach is particularly useful in public health scenarios, offering a non-invasive method to monitor the health of populations.
The Corporate segment encompasses all costs and activities not directly tied to the Drones or Vital Intelligence segments. This includes administrative functions and strategic initiatives aimed at supporting the overall growth and sustainability of the company.
Draganfly has made significant strides in recent years, achieving key financial and operational milestones. The company continues to expand its product offerings and forge strategic partnerships, positioning itself as a pioneer in the UAV industry. For instance, recent financial highlights for Q4 2023 and early 2024 underscore Draganfly's robust performance and growth trajectory.
Investors and stakeholders can stay informed about Draganfly's developments by visiting the company's official website at www.draganfly.com. For additional investor information, the company's profiles on the CSE, NASDAQ, and Börse Frankfurt are excellent resources.
For media inquiries, please contact Arian Hopkins at media@draganfly.com. Company-related queries can be directed to info@draganfly.com.
Draganfly Inc. (NASDAQ: DPRO) is attending the 2022 Special Operations Forces Industry Conference (SOFIC) in Tampa, Florida, from May 16-19, 2022. The event gathers the SOF community to enhance collaboration across sectors. Draganfly will showcase its Medical Response and Search and Rescue Drone platforms, emphasizing their role in aiding critical missions.
Draganfly (NASDAQ: DPRO) has partnered with NuGen M.D. and Coldchain Delivery Systems to deploy Medical Response Drones for delivering needle-free injection devices filled with insulin to conflict areas in Ukraine. The initiative aims to address the urgent medical needs of over 2.3 million diabetics in Ukraine, particularly in war-torn regions. The initial donation includes 50 InsuJet™ devices and 5,000 syringes. Draganfly will initially supply 10 drones, with a potential order for up to 200 units. This collaboration is critical for ensuring access to essential medical supplies during the ongoing crisis.
Draganfly (NASDAQ: DPRO) announced its partnership with Airworx for the 2022 SC Public Safety Unmanned Systems Summit in Greenville, SC, on May 12-13. The event aims to showcase drone technologies for public safety, featuring Draganfly's Drone as First Responder and AI Vital Intelligence platforms. A report forecasts the public safety drone market to hit $3 billion by 2025, with agencies expanding their drone pilot programs. Draganfly's President, Cameron Chell, emphasized the platforms' potential to enhance efficiency and response times in law enforcement operations.
Draganfly reported a notable 32.8% year-over-year revenue increase for Q1 2022, totaling $2,044,562, primarily from organic product sales. Gross profit surged 58.5% to $301,143, with improved gross margin at 39.9%. The comprehensive loss narrowed to $6.29 million, significantly lower than the previous year’s $44.9 million. Cash reserves decreased to $19.6 million. Notable developments include a 200-unit order for Medical Response and Search and Rescue Drones and a partnership with Fobi AI to enhance in-person event safety.
Draganfly Inc. (NASDAQ: DPRO) has announced significant governance changes, including the appointment of John Mitnick as Chairman of the Board. Mitnick, with extensive legal and executive experience, aims to enhance the company’s strategic growth and shareholder value. Cameron Chell will serve as both CEO and President. Additionally, Paul Mullen has been appointed as the first Chief Operating Officer, tasked with overseeing operational growth. Draganfly focuses on innovative drone solutions across various sectors, reaffirming its position as an industry leader.
Draganfly Inc. (NASDAQ: DPRO) has announced a shareholder update call scheduled for May 10, 2022, at 2:30 p.m. PDT/5:30 p.m. EDT. CEO Cameron Chell will discuss the company's key milestones, while CFO Paul Sun will review Q1 2022 financial results, set to be filed later that day. Following the prepared remarks, pre-submitted questions will be addressed by Lead Director Scott Larson. This call seeks to enhance transparency and engage investors on the company’s progress.
Draganfly Inc. (NASDAQ: DPRO) announced its commitment to provide five specialized Medical Response Drones to Revived Soldiers Ukraine (RSU), funded by DroneAid: Ukraine. These drones are designed for delivering temperature-sensitive medical supplies to inaccessible areas in Ukraine amid urgent humanitarian needs. The order builds on a prior request involving up to 200 drone units. CEO Cameron Chell emphasized the critical role of these drones in supporting humanitarian efforts. The initiative aims to alleviate the ongoing crisis in Ukraine by enhancing the efficiency of medical aid delivery.
Draganfly has successfully deployed its first Medical Response Drone to Revived Soldiers Ukraine. This drone is designed to deliver up to 35 pounds of temperature-sensitive medical supplies, including vaccines and pharmaceuticals. The deployment, completed on May 1, 2022, included training for RSU's drone operators via virtual sessions. CEO Cameron Chell emphasized the drone's role in facilitating timely medical aid during the ongoing crisis in Ukraine. Additionally, Draganfly has received an order for 10 more drones for immediate deployment.
Draganfly Inc. (NASDAQ: DPRO) has successfully deployed its Smart Vital Kiosks in Perry County, Alabama, through the Perry County School District. These kiosks enable health screenings, including temperature, blood pressure, and oxygen saturation, enhancing privacy while capturing anonymous data. This initiative aligns with the U.S. Department of Education's focus on prioritizing health and safety in schools post-COVID-19. Draganfly's platform aims to improve health security for students and staff, reinforcing the commitment to a safe learning environment.
Kin Communications has partnered with NuGen Medical Devices to raise funds for insulin delivery to Ukrainian diabetics affected by ongoing conflict. The initiative aims to address the urgent need for insulin, particularly for Type 1 diabetics in high-conflict areas. The fundraising target is $250,000, with a broader goal of $5 million to support those in need. NuGen will donate insulin delivery systems, and the partnership includes Draganfly and Coldchain Technology Services to ensure effective distribution using medical response drones.
FAQ
What is the current stock price of Draganfly Common Shares (DPRO)?
What is the market cap of Draganfly Common Shares (DPRO)?
What does Draganfly Inc. specialize in?
Where is Draganfly Inc. headquartered?
What are the main segments of Draganfly's operations?
What is the primary source of revenue for Draganfly Inc.?
What is the Vital Intelligence segment about?
How can I stay updated with Draganfly's latest news?
How can I contact Draganfly's media relations?
Where can I find investor information about Draganfly?
What recent financial performance highlights has Draganfly achieved?
How do Draganfly's products benefit emergency services?
